FDA Urges Caution with COX-2 Drugs
302680
Consumers are advised that all over-the-counter pain medications should be used only as the label directs. While Celebrex and Bextra remain on the market, Merck recently withdrew its COX-2 Vioxx because of the increased risk of cardiovascular events.
68020
Federal health officials  yesterday proposed sterner warning labels for acetaminophen, aspirin and ibuprofen, again cautioning millions of Americans who take the nonprescription pain relievers regularly of potentially serious side effects.
105508
Two leading heart experts called for urgent investigations on Wednesday into whether all painkilling drugs known as COX-2 inhibitors may raise the risk of heart attack in some people.
320247
The U.S. Food and Drug  Administration warned Pfizer Inc. over television and print  advertisements for its painkillers Celebrex and Bextra, saying  they mislead consumers, according to a letter made public on  Wednesday.
747629
The U.S. Food and Drug Administration on Monday issued a warning to patients taking the painkiller naproxen after a government study showed the over-the-counter medicine can cause an increased risk of heart problems.
224987
Doctors should limit use of Pfizer Inc.&#39;s Celebrex and Bextra pain drugs while regulators continue to weigh their cardiovascular risks, the US Food and Drug Administration said.
742151
The safety of Celebrex and other pain relievers was questioned Wednesday as scientists in the United States and regulatory agencies in Europe said they feared such drugs might raise the same risk of heart problems as those blamed on the arthritis medicine Vioxx.    One key researcher charged the U.S...
86379
One of America&#39;s leading heart specialists is calling for less aggressive direct-to-consumer advertising of the arthritis pain drugs known as cox-2 inhibitors, in light of recent reports linking them to increased risk of heart attack and stroke.
665144
More evidence of how painkillers called COX-2 inhibitors can raise the risk of heart disease was published Monday, showing Pfizer Inc.'s Bextra can triple the risk of heart attack and stroke in certain patients.
16125
The Food and Drug Administration yesterday ordered a review of all prevention studies involving drugs such as Celebrex and Bextra, which have been associated with increased risk of heart problems. The agency also urged the public to limit use of over-the-counter pain medications.
466531
New evidence shows all popular arthritis painkillers known as COX-2 inhibitors may put users at greater risk of heart attacks and strokes, the latest addition to the recent crop of safety concerns for the drugs.
300996
Research shows that the dangers linking the arthritis drug Vioxx, a COX-2 inhibitor, to an increased risk of heart attacks, were known in 2000, which should have led to its immediate recall.
55610
The Food and Drug Administration recommended Thursday that doctors limit prescriptions for the popular pain pills Celebrex and Bextra because recent
31204
The story of COX-2 drugs is an example of how difficult it is for the F.D.A. to monitor the safety of drugs after they have been approved for the market.
577633
The safety of Celebrex and other pain relievers was questioned Wednesday as scientists in the United States and regulatory agencies in Europe said they feared such drugs might raise the same risk of heart problems as those blamed on the arthritis medicine Vioxx.
130323
BEIJING, Dec. 24 -- FDA has recommended on Thursday that doctors and users are cautious to use the controversial painkillers -- Pfizer Inc.
443157
U.S. health officials Thursday called on doctors to limit prescribing Pfizer Inc. painkillers Celebrex and Bextra in light of recent evidence that they may increase the risk of heart attack and stroke.